Vident Investment Advisory, LLC Neurocrine Biosciences Inc Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $345,521 - $460,782	-4,338 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$86.18 - $99.03 $53,000 - $60,903	-615 Reduced 12.42%	4,338 $416,000
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $24,950 - $28,533	279 Added 5.97%	4,953 $482,000
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $32,313 - $44,058	-369 Reduced 7.32%	4,674 $455,000
Q4 2020 Feb 08, 2021	SELL	$86.91 - $108.33 $234,483 - $292,274	-2,698 Reduced 34.85%	5,043 $483,000
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $242,611 - $340,983	-2,523 Reduced 24.58%	7,741 $744,000
Q2 2020 Jul 17, 2020	BUY	$85.09 - $130.36 $323,767 - $496,019	3,805 Added 58.91%	10,264 $1.25 Million
Q1 2020 May 12, 2020	SELL	$75.11 - $113.76 $5,633 - $8,532	-75 Reduced 1.15%	6,459 $559,000
Q4 2019 Feb 11, 2020	SELL	$86.8 - $118.57 $71,523 - $97,701	-824 Reduced 11.2%	6,534 $702,000
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $62,613 - $75,820	747 Added 11.3%	7,358 $663,000
Q2 2019 Aug 12, 2019	BUY	$72.24 - $91.27 $46,161 - $58,321	639 Added 10.7%	6,611 $558,000
Q1 2019 May 08, 2019	BUY	$69.31 - $91.53 $104,796 - $138,393	1,512 Added 33.9%	5,972 $526,000
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $32,520 - $59,195	476 Added 11.95%	4,460 $318,000
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $63,283 - $80,544	-640 Reduced 13.84%	3,984 $490,000
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $3,915 - $5,511	52 Added 1.14%	4,624 $454,000
Q1 2018 May 14, 2018	BUY	$75.88 - $92.43 $144,020 - $175,432	1,898 Added 70.98%	4,572 $345,000
Q4 2017 Feb 15, 2018	BUY	$58.53 - $77.59 $156,509 - $207,475	2,674	2,674 $207,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.77 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.25 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$644 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$322 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$233 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account